Arcturus Therapeutics Holdings Inc
ARCTHealthcare|Biotechnology|USA
$6.97
-0.19 (-2.65%)
Tangible Book
$6.73
About
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Stock Price
-51.9%(1Y)
Pipeline Summary
16 total trials7
Phase 1
9
Phase 2
2
Phase 3
0
Phase 4
Completed: 9Terminated: 3NOT_YET_RECRUITING: 2Recruiting: 2
Active Trials (2)
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
NCT06747858Cystic Fibrosis
Phase 2Recruiting
Enrollment: 33 participants
A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD
NCT06488313OTC Deficiency
Phase 2Recruiting
Enrollment: 9 participants
BioScore
5.7/10
Watchlist
Ownership
Recent Insider Trades
SASSINE ANDYBUY
2025-08-151,238 shares @ $16.56
Chivukula PadSELL
2024-10-1512,000 shares @ $20.76
SASSINE ANDYSELL
2024-06-1250,000 shares @ $32.03
Chivukula PadSELL
2024-06-05114 shares @ $45
Chivukula PadSELL
2024-06-0326,000 shares @ $40.01
Recent News
2026-07-02 12:00:07
2026-07-02 10:30:33
Data last updated: Jul 13, 2026, 12:49 PM